| [1] |
VLASOVA A, AMIMO J, SAIF L. Porcine rotaviruses: epidemiology, immune responses and control strategies. Viruses, 2017, 9(3): 48.
doi: 10.3390/v9030048
|
| [2] |
DIAN Z Q, SUN Y, ZHANG G Q, XU Y, FAN X, YANG X M, PAN Q W, PEPPELENBOSCH M, MIAO Z J. Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis. Critical Reviews in Microbiology, 2021, 47(5): 580-595.
doi: 10.1080/1040841X.2021.1907738
|
| [3] |
TAO R, CHANG X J, ZHOU J Z, ZHU X J, YANG S S, LI K M, GU L Q, ZHANG X H, LI B. Molecular epidemiological investigation of group A porcine rotavirus in East China. Frontiers in Veterinary Science, 2023, 10: 1138419.
doi: 10.3389/fvets.2023.1138419
|
| [4] |
|
|
ZHOU Q, CHEN X F, KAN R C, LI Y, CAO H, PENG Y L, ZHANG B. Molecular epidemiological investigation of porcine group a rotavirus in Sichuan from 2017 to 2019. Scientia Agricultura Sinica, 2021, 54(5): 1063-1072. doi: 10.3864/j.issn.0578-1752.2021.05.017. (in Chinese)
|
| [5] |
LV Y N, TONG Z, LIU J Q, ZHANG Z R, WANG C C, ZENG Y, LIU P X, ZONG X, CHEN G S, CHEN H C, TAN C. Molecular characterization and pathogenicity analysis of porcine rotavirus A. Viruses, 2024, 16(12): 1842.
doi: 10.3390/v16121842
|
| [6] |
WU L, JING Z Y, PAN Y D, GUO L J, LI Z X, FENG L, TIAN J. Emergence of a novel pathogenic porcine G1P [7] rotavirus in China. Virology, 2024, 598: 110185.
doi: 10.1016/j.virol.2024.110185
|
| [7] |
WANG J X, ZHOU J Z, ZHU X J, BIAN X Y, HAN N, FAN B C, GU L Q, CHENG X, LI S F, TAO R, LI J Z, ZHANG X H, LI B. Isolation and characterization of a G9P [23] porcine rotavirus strain AHFY2022 in China. Microbial Pathogenesis, 2024, 190: 106612.
doi: 10.1016/j.micpath.2024.106612
|
| [8] |
MONTEAGUDO L V, BENITO A A, LÁZARO-GASPAR S, ARNAL J L, MARTIN-JURADO D, MENJON R, QUÍLEZ J. Occurrence of rotavirus a genotypes and other enteric pathogens in diarrheic suckling piglets from Spanish swine farms. Animals, 2022, 12(3): 251.
doi: 10.3390/ani12030251
|
| [9] |
KUMAR D, SHEPHERD F K, SPRINGER N L, MWANGI W, MARTHALER D G. Rotavirus infection in swine: Genotypic diversity, immune responses, and role of gut microbiome in rotavirus immunity. Pathogens, 2022, 11(10): 1078.
doi: 10.3390/pathogens11101078
|
| [10] |
BÁNYAI K, KEMENESI G, BUDINSKI I, FÖLDES F, ZANA B, MARTON S, VARGA-KUGLER R, OLDAL M, KURUCZ K, JAKAB F. Candidate new rotavirus species in Schreiber’s bats, Serbia. Infection, Genetics and Evolution, 2017, 48: 19-26.
doi: 10.1016/j.meegid.2016.12.002
|
| [11] |
PESAVENTO J B, CRAWFORD S E, ESTES M K, VENKATARAM PRASAD B V. Rotavirus proteins: Structure and assembly. Current Topics in Microbiology and Immunology, 2006, 309: 189-219.
pmid: 16913048
|
| [12] |
卞贤宇, 李素芬, 王建新, 韩楠, 卢洪婷, 程曦, 周金柱, 陶然, 朱雪蛟, 董海龙, 张雪寒, 李彬. 猪轮状病毒主要非结构蛋白的原核表达、抗体制备及应用. 中国农业科学, 2024, 57 (17): 3494-3506. doi: 10.3864/j.issn.0578-1752.2024.17.014.
|
|
BIAN X Y, LI S F, WANG J X, HAN N, LU H T, CHENG X, ZHOU J Z, TAO R, ZHU X J, DONG H L, ZHANG X H, LI B. Prokaryotic expression, antibody preparation and application of major non- structural proteins of porcine rotavirus. Scientia Agricultura Sinica, 2024, 57(17): 3494-3506. doi: 10.3864/j.issn.0578-1752.2024.17.014. (in Chinese)
|
| [13] |
SUN X M, LI D D, DUAN Z J. Structural basis of glycan recognition of rotavirus. Frontiers in Molecular Biosciences, 2021, 8: 658029.
doi: 10.3389/fmolb.2021.658029
|
| [14] |
ASENSIO-COB D, RODRÍGUEZ J M, LUQUE D. Rotavirus particle disassembly and assembly in vivo and in vitro. Viruses, 2023, 15(8): 1750.
doi: 10.3390/v15081750
|
| [15] |
CLARK S M, ROTH J R, CLARK M L, BARNETT B B, SPENDLOVE R S. Trypsin enhancement of rotavirus infectivity: Mechanism of enhancement. Journal of Virology, 1981, 39(3): 816-822.
pmid: 6169841
|
| [16] |
HUANG Y, SONG F B, ZENG Y J, SUN H, SHENG R F, WANG X C, LIU L Q, LUO G X, JIANG Y N, CHEN Y L, et al. A single residue switch mediates the broad neutralization of Rotaviruses. Nature Communications, 2025, 16: 838.
doi: 10.1038/s41467-025-56114-3
|
| [17] |
NAIR N, FENG N G, BLUM L K, SANYAL M, DING S Y, JIANG B M, SEN A, MORTON J M, HE X S, ROBINSON W H, GREENBERG H B. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Science Translational Medicine, 2017, 9(395): eaam5434.
|
| [18] |
RUGGERI F M, GREENBERG H B. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. Journal of Virology, 1991, 65(5): 2211-2219.
doi: 10.1128/JVI.65.5.2211-2219.1991
pmid: 1850007
|
| [19] |
HERRMANN T, TORRES R, SALGADO E N, BERCIU C, STODDARD D, NICASTRO D, JENNI S, HARRISON S C. Functional refolding of the penetration protein on a non-enveloped virus. Nature, 2021, 590(7847): 666-670.
doi: 10.1038/s41586-020-03124-4
|
| [20] |
YODER J D, TRASK S D, VO T P, BINKA M, FENG N G, HARRISON S C, GREENBERG H B, DORMITZER P R. VP5* rearranges when rotavirus uncoats. Journal of Virology, 2009, 83(21): 11372-11377.
doi: 10.1128/JVI.01228-09
pmid: 19692464
|
| [21] |
GRAHAM K L, TAKADA Y, COULSON B S. Rotavirus spike protein VP5* binds alpha2beta1 integrin on the cell surface and competes with virus for cell binding and infectivity. The Journal of General Virology, 2006, 87(Pt 5): 1275-1283.
doi: 10.1099/vir.0.81580-0
|
| [22] |
FLEMING F E, GRAHAM K L, TANIGUCHI K, TAKADA Y, COULSON B S. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1. Archives of Virology, 2007, 152(6): 1087-1101.
pmid: 17318737
|
| [23] |
QIAO M L, LI M Z, LI Y, WANG Z W, HU Z Q, QING J, HUANG J P, JIANG J P, JIANG Y Q, ZHANG J Y, et al. Recent molecular characterization of porcine rotaviruses detected in China and their phylogenetic relationships with human rotaviruses. Viruses, 2024, 16(3): 453.
doi: 10.3390/v16030453
|
| [24] |
THEUNS S, DESMARETS L M B, HEYLEN E, ZELLER M, DEDEURWAERDER A, ROUKAERTS I D M, VAN RANST M, MATTHIJNSSENS J, NAUWYNCK H J. Porcine group a rotaviruses with heterogeneous VP7 and VP4 genotype combinations can be found together with enteric bacteria on Belgian swine farms. Veterinary Microbiology, 2014, 172(1/2): 23-34.
doi: 10.1016/j.vetmic.2014.04.002
|
| [25] |
王奕斐, 洪大林, 米雪, 杜琛, 边金妮, 陈樱, 韦祖樟, 黄伟坚, 欧阳康. 猪轮状病毒VP4、VP6蛋白原核表达及多克隆抗体的制备. 中国兽医学报, 2022, 42 (11): 2171-2180.
|
|
WANG Y F, HONG D L, MI X, DU C, BIAN J N, CHEN Y, WEI Z Z, HUANG W J, OUYANG K. Prokaryotic Expression of porcine rotavirus VP4 and VP6 proteins and preparation of polyclonal antibodies. Chinese Journal of Veterinary Science, 2022, 42(11): 2171-2180. (in Chinese)
|
| [26] |
迟延彬. A群猪轮状病毒VP7蛋白单抗的制备及其抗原表位鉴定[D]. 哈尔滨: 东北农业大学, 2014.
|
|
CHI Y B. Preparation of monoclonal antibodies against porcine group A rotavirus VP7 protein and identification of its antigenic epitopes[D]. Harbin: Northeast Agricultural University, 2014. (in Chinese)
|
| [27] |
李科茫, 周金柱, 周俊明, 牛贝贝, 武琦, 郭容利, 张雪寒, 朱雪蛟, 李彬, 粟硕. 猪A群轮状病毒VP6单克隆抗体的制备和初步鉴定. 畜牧与兽医, 2023, 55 (4): 79-85.
|
|
LI K M, ZHOU J Z, ZHOU J M, NIU B B, WU Q, GUO R L, ZHANG X H, ZHU X J, LI B, SU S. Preparation and preliminary identification of monoclonal antibodies against porcine group a rotavirus VP6 protein. Animal Husbandry & Veterinary Medicine, 2023, 55(4): 79-85. (in Chinese)
|
| [28] |
TANG X C, LI S F, ZHOU J Z, BIAN X Y, WANG J X, HAN N, ZHU X J, TAO R, WANG W, SUN M, et al. Recombinant bivalent subunit vaccine combining truncated VP 4 from P [7] and P [23] induces protective immunity against prevalent porcine rotaviruses. Journal of Virology, 2024, 98(5): e0021224.
|
| [29] |
WANG X, LI M, LIN Z J, PAN H R, TANG Z M, ZHENG Z Z, LI S W, ZHANG J, XIA N S, ZHAO Q J. Multifaceted characterization of recombinant protein-based vaccines: an immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine. Vaccine, 2018, 36(50): 7650-7658.
doi: S0264-410X(18)31486-5
pmid: 30396752
|
| [30] |
|
|
FENG C Y, ZHANG Z X, LIU Y F, HUANG L, WENG C J. Preparation of monoclonal antibody against African swine fever virus p54 protein and identification of its epitope. Scientia Agricultura Sinica, 2024, 57(19): 3936-3944. doi: 10.3864/j.issn.0578-752.2024.19.015. (in Chinese)
|
| [31] |
LI S F, BIAN X Y, WANG J X, WANG D D, ZHOU J Z, SONG J P, WANG W, HAN N, ZHOU J M, LI Y C, et al. VP4-Specific IgA level as a correlate of neutralizing antibody and fecal shedding of porcine rotavirus infection. Veterinary Microbiology, 2025, 304: 110501.
doi: 10.1016/j.vetmic.2025.110501
|
| [32] |
LI S F, TANG X C, ZHOU J Z, BIAN X Y, WANG J X, GU L Q, ZHU X J, TAO R, SUN M, ZHANG X H, LI B. The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response. Virology, 2024, 597: 110130.
doi: 10.1016/j.virol.2024.110130
|
| [33] |
ZENG Y J, SONG F B, LUO G X, YANG H, LI C, LIU W, LI T D, ZHANG S Y, WANG Y B, HUANG C H, et al. Generation and characterization of mouse monoclonal antibodies against the VP 4 protein of group A human rotaviruses. Antiviral Research, 2022, 207: 105407.
doi: 10.1016/j.antiviral.2022.105407
|
| [34] |
JENNI S, LI Z L, WANG Y H, BESSEY T, SALGADO E N, SCHMIDT A G, GREENBERG H B, JIANG B M, HARRISON S C. Rotavirus VP4 epitope of a broadly neutralizing human antibody defined by its structure bound with an attenuated-strain virion. Journal of Virology, 2022, 96(16): e0062722.
doi: 10.1128/jvi.00627-22
|
| [35] |
LI C, LUO G X, ZENG Y J, SONG F B, YANG H, ZHANG S Y, WANG Y B, LI T D, GE S X, XIA N S. Establishment of sandwich ELISA for quality control in rotavirus vaccine production. Vaccines, 2022, 10(2): 243.
doi: 10.3390/vaccines10020243
|
| [36] |
毛玎懿, 孙波涛, 戴琦, 李文良, 李梅珍, 陈艳, 赵冰倩, 陈婧, 周斌. 猪A群轮状病毒VP4单克隆抗体的制备和初步鉴定. 畜牧与兽医, 2025, 57(6):77-82.
|
|
MAO D Y, SUN B T, DAI Q, LI W L, LI M Z, CHEN Y, ZHAO B Q, CHEN J, ZHOU B. Preparation and preliminary identification of monoclonal antibodies against porcine group A rotavirus VP4 protein. Animal Husbandry & Veterinary Medicine, 2025, 57(6): 77-82. (in Chinese)
|
| [37] |
PADILLA-NORIEGA L, FIORE L, RENNELS M B, LOSONSKY G A, MACKOW E R, GREENBERG H B. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with Rhesus rotavirus. Journal of Clinical Microbiology, 1992, 30(6): 1392-1397.
doi: 10.1128/jcm.30.6.1392-1397.1992
|
| [38] |
SEDOVA E S, SCHERBININ D N, LYSENKO A A, ALEKSEEVA S V, ARTEMOVA E A, SHMAROV M M. Non-neutralizing antibodies directed at conservative influenza antigens. Acta Naturae, 2019, 11(4): 22-32.
doi: 10.32607/20758251-2019-11-4-22-32
pmid: 31993232
|
| [39] |
WEIDENBACHER P A B, WALTARI E, DE LOS RIOS KOBARA I, BELL B N, MORRIS M K, CHENG Y C, HANSON C, PAK J E, KIM P S. Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors. Nature Chemical Biology, 2022, 18(11): 1270-1276.
doi: 10.1038/s41589-022-01140-1
pmid: 36076082
|